INSPECT-SR: a tool for assessing trustworthiness of randomised controlled trials.
Wilkinson J., Heal C., Flemyng E., Antoniou GA., Aburrow T., Alfirevic Z., Avenell A., Barbour V., Berghella V., Bishop DVM., Bordewijk EM., Brown NJL., Christopher J., Clarke M., Dahly D., Dennis J., Dicker P., Dumville J., Frankish H., Grey A., Grohmann S., Gurrin LC., Hayden JA., Heathers JAJ., Hunter KE., Hussey I., Jung L., Lam E., Lasserson TJ., Lensen S., Li T., Li W., Liu J., Loder E., Lundh A., Meyerowitz-Katz G., Mol BW., Naudet F., Noel-Storr A., O'Connell NE., Parker L., Redberg RF., Redman BK., Richardson R., Seidler AL., Sheldrick K., Sydenham E., van Wely M., Vorland CJ., Wang R., Weibel S., Wjst M., Bero L., Kirkham JJ.
The integrity of evidence synthesis is threatened by problematic randomised controlled trials (RCTs). These are RCTs where there are serious concerns about the trustworthiness of the data or findings. This could be due to research misconduct, including fraud, or due to honest critical errors. If these RCTs are not detected, they may be inadvertently included in systematic reviews and guidelines, potentially distorting their results. To address this problem, the INSPECT-SR (INveStigating ProblEmatic Clinical Trials in Systematic Reviews) tool has been developed to assess the trustworthiness of RCTs. This will allow problematic RCTs to be identified and excluded from systematic reviews. This paper describes the development of INSPECT-SR. The tool and an associated guidance document are presented.